AI analysis of a retinal photograph may help flag people who need a closer cardiovascular assessment, but it does not measure blood pressure or cholesterol and cannot replace either test. In a 2026 U.S. evaluation, the CLAiR system’s result was compared with a 10-year risk estimate calculated from clinical factors—not with blood pressure and cholesterol tests one by one. The appropriate role for now is as a possible screening adjunct, followed by clinician-led assessment.
What each approach tells you
These approaches provide different kinds of information. Retinal imaging creates a picture of small blood vessels at the back of the eye. An AI system can analyze patterns in that image and assign a cardiovascular risk classification. It does not directly read a person’s blood pressure or produce cholesterol values.
| Approach | What it supplies | How it was used in the cited evidence | What it cannot establish by itself |
|---|---|---|---|
| AI analysis of a retinal image | An image-derived risk classification based on retinal blood-vessel patterns | CLAiR results were compared with a standard 10-year ASCVD risk category | It is not a blood pressure reading or lipid profile, and it is not a substitute for a standard cardiovascular evaluation. ACC, 2026 |
| Blood pressure measurement | A measured blood pressure value | Blood pressure was one of the clinical inputs in the standard risk estimate used for comparison | One reading is only one input to a broader assessment. NHLBI blood pressure guidance |
| Cholesterol or lipid testing | Measured lipid values used in cardiovascular risk assessment and lipid management | Cholesterol data were included in the comparator risk estimate | A retinal image cannot provide a lipid profile; testing and interpretation belong in clinical care. 2026 AHA/ACC dyslipidemia guideline hub |
A 10-year ASCVD estimate is a calculated risk category, not a diagnosis of heart disease. It combines several factors—in this study, age, sex, smoking status, blood pressure, and cholesterol. Comparing an eye-based classification with that estimate is not the same as showing that an eye scan can replace a blood pressure check or lipid panel.
What the 2026 CLAiR evaluation found
The American College of Cardiology reported a prospective evaluation of CLAiR involving 874 people ages 40–75 at 10 U.S. eye-care and primary-care sites. Participants were not taking lipid-lowering medication and had no known atherosclerosis. In this study group, 26% had a standard-estimator 10-year ASCVD risk of at least 7.5%.
#1 Best Overall
- Clinically Accurate: Easy Operation by two buttons, Advanced Accuracy, No Calibration required.
- Large Multi-Color Backlit Display: The large, oversized numbers make reading the results from this upper arm blood pressure monitoring device a breeze. Coded (GREEN/YELLOW/RED) display tells if your blood pressure readings are optimal or not.
- Easy Management: Manage and track up to 99 readings on your blood pressure monitor and unlimited readings on your smartphone with iHealth's free iOS and Android applications ( iOS 12.0 or later. Android 9.0 or later.Requires Bluetooth 4.0.and up).
- Heart Rhythm Disturbances: This unit automatically identifies and alerts you to any heart rhythm disturbances. If detected, a warning symbol will be displayed after the measurement is taken.
- What You Get: 1 x blood pressure monitor that meets ESH 2010 performance standards, 4 AAA batteries, 1 wide range cuff that fits upper arms with Circumference of 8.7"-16.5" (22-42cm),1 Instruction manual, our worry-free 12-month warranty and friendly California-based customer service.
Relative to the study’s standard-estimator classification, CLAiR reported 91.1% sensitivity and 86.2% specificity. Those figures describe how the system identified positive and negative cases against that comparator in the evaluated group. They do not show fewer heart attacks, strokes, or deaths, nor do they establish that the system can safely guide treatment on its own. The report also said 94% of acquired images were usable by the AI system. ACC report
The report estimated about five minutes for retinal imaging and about 30 seconds for an algorithm result; those are study workflow estimates, not a guarantee of timing at every clinic. The study was funded by Toku, CLAiR’s developer, and its study lead, Michael V. McConnell, MD, is identified by ACC as Toku’s chief health officer. That context matters when weighing an encouraging early evaluation.
Rank #2
- One-Button Design: This Oklar blood pressure monitor features a one-button operation, making measurement easy and convenient; with just a touch, you can quickly take a measurement and get an accurate reading
- Large LED Display: The backlit LED screen with clear digits makes it easy for anyone to read quickly; you can get readings within 1 minute, and it's user-friendly for the elderly
- Stores Up to 240 Readings: Supports two users, storing 120 readings per user; this feature makes it easy to track and monitor blood pressure trends for you and your family over time
- Convenient Dual Power Supply: Allows to operate by using either 3AA batteries or a Type-C interface (Notice: Use the provided Type-C cable if no batteries are installed; This product is not rechargeable) ; its compact size and dual supply capabilities ensure it's ready for use at home or on the go
- Adjustable Arm Cuff: The arm cuff range from 8.7 - 15.7 inches (22-40 cm) fits your size, ensuring a comfortable and secure fit for most adults
What the results do—and do not—mean for patients
It may help identify people who need follow-up
An image-based screen could bring risk to someone’s attention during an eye-care visit, including someone who has not had a thorough cardiovascular assessment. McConnell described it as a potential way to increase awareness, not replace standard evaluation. A positive result should prompt a conversation with a clinician and guideline-based assessment.
It is not proof of clinical benefit or a treatment decision
The evaluation tested agreement with a calculated risk category. It did not establish that screening improves health outcomes or that a retinal result alone should start, stop, or change preventive treatment. The ACC report specifically notes that clear referral pathways from an elevated eye-exam result to clinical care remain necessary.
Rank #3
- ✅ Easy to Use – One-button operation makes checking your blood pressure simple and hassle-free—no setup or calibration required. All your readings are clearly displayed on a large 3.6-inch screen.
- ✅ High Accuracy – Trusted, clinically comparable results. The cuff pressure accuracy is ±3 mmHg (±0.4 kPa), and the pulse rate accuracy is within ±5%, ensuring reliable and precise measurements every time.
- ✅ Two Power Options – Powered by 4 AAA batteries or via a convenient Type-C charging port (no include cable), giving you flexible power choices at home or on the go.
- ✅ Personalized Features – The adjustable cuff fits arm sizes from 8.6" to 16.5". The monitor detects incorrect posture during measurement, uses color-coded indicators to classify blood pressure levels, alerts you to irregular heartbeats, and more.
- ✅ Dual-User Mode – Perfect for family use. The monitor supports two user profiles, with each capable of storing up to 99 readings, making it easy to track and compare historical data.
Study participants do not represent everyone
Because the cohort excluded people with known atherosclerosis and those taking lipid-lowering medication, the findings should not be assumed to apply to all patients. ACC reports that CLAiR was not designed for pregnant people or people with advanced eye disease, which can affect retinal vessels.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Availability and remaining research questions
ACC reported that CLAiR received FDA Breakthrough Device designation and that the U.S. evaluation results would support an FDA submission. Breakthrough Device designation is not FDA marketing authorization, so it should not be read as proof that the system is cleared or authorized for routine use. The ACC report also says retinal imaging is not covered by every U.S. vision plan and may involve an extra charge. Ask the clinic what is available, whether it is appropriate for you, and what it costs.
Rank #4
- Convenient Dual User Mode: Store up to 240 readings for two users, allowing easy tracking and comparison of measurements
- Fast and Accurate Measurements: Our fully automatic wrist blood pressure machine provides fast and precise results, simply press the "START/STOP" button, and the measurement process takes 35 seconds; the device automatically turns off after 60 seconds of inactivity
- Voice Broadcast Design: Our automatic blood pressure cuff features a voice broadcast function, making it ideal for individuals with poor eyesight; you can adjust the volume or turn off the sound using the SET and MEM buttons
- Large LED Backlit Display: The large LED screen of our blood pressure monitor features clear numbers, ensuring easy readability even in low-light conditions, enjoy a hassle-free visual experience
- Portable Rechargeable Blood Pressure Monitor: Equipped with a built-in rechargeable battery and Type-C cable for convenient charging anytime, eliminating the need for battery replacements and ensuring you can easily monitor your health (Note: Charging adapter not included in the packaging)
A 2024 NHLBI workshop roadmap describes retinal vascular imaging as an active research area, not an established cardiovascular screening standard. It identifies needs including consistent high-quality image capture, studies that follow diverse populations over time, better measurement of retinal biomarkers, and stronger integration with clinical data. These priorities help explain why promising image-analysis results still need further evaluation before their role in routine care is settled. NHLBI workshop roadmap, 2024
Quick Recap
Best Value
- CONFIDENCE IN EVERY READING: The OMRON Iron Upper Arm Blood Pressure Monitor's Advanced Accuracy Technology helps you monitor your heart health
- SAFEGUARD YOUR HEART: OMRON's Irregular Heart Beat Detection identifies heartbeat irregularities during routine blood pressure measurements, helping you and your doctor determine if treatment or further evaluation is needed
- START YOUR DAY WITH CONFIDENCE: Count on quick and accurate readings with simple one-touch operation; Just press one button; Regular monitoring can reveal irregular fluctuations before they lead to serious complications
- MORE ACCURATE RESULTS: Body Movement Detection alerts help enhance the accuracy of your blood pressure readings
- READY OUT OF THE BOX: Includes everything you need for your blood pressure kit; OMRON monitor, wide-range D-ring blood pressure cuff (fits arms 9"-17"), instruction manual, and quick start guide
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
